ClinicalTrials.Veeva

Menu

Long-term Neurodevelopmental Disorders of Prematurely Born Children and Parental Experience (PREMA7)

C

Central Hospital, Nancy, France

Status

Completed

Conditions

Neurodevelopmental Abnormality

Study type

Observational

Funder types

Other

Identifiers

NCT04607109
2020PI166

Details and patient eligibility

About

Thanks to the evolution in knowledge and technical advances in premature newborn intensive care, the survival of very premature infants is now possible. However, prognosis remain sometimes uncertain.

In 2011, the Epipage 2 study showed a significant improvement as compared with the 1997 Epipage1 study with a decrease in mortality and an increase of the survival rate without severe morbidity of 14% for preterm babies born between 25 and 29 weeks and 6% for babies born between 30 and 31 weeks.

However, surviving babies without initial major deficiencies, may later show problems in terms of growth, sensory - motor and/or neuro-psychologic development. This untoward evolution lead to social and family interaction disorders and school difficulties.

In this context, a perinatal care network was created for each Region in France, making it possible to take care of these vulnerable children early on and all along their development. A retrospective study will evaluate 97 pre-term babies born before 33 weeks in 2012 and who are taken care of at Nancy as part of the Lorraine regional network program "Rafael" until they are 7 years old.

The objective is to evaluate objectively the neurocognitive and school abilities of these children at the age of 7.

At 8 years of age, a secondary measure of outcome will be the impact of the eventual neurocognitive consequences on the quality of their family life, on the behavior of the child and the parents' feelings. This way more options to improve the way they are taken care of will be available.

Enrollment

238 patients

Sex

All

Ages

7 to 8 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • all children prematurely born between 24 and 33 completed week during 2012
  • and involved in the Lorraine Perinatal Follow-up program at 7 years old

Exclusion criteria

  • Children not able to respond to the EDA evaluation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems